SCHEMBL18566175

SCHEMBL18566175

Cn1c2ccccc2c2cc3c4ccc5ccccc5c4p(-c4ccccc4)c3cc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR3 P46089 1/20 0.41
▸ KIF11 P52732 1/20 0.40
▸ KDM4E B2RXH2 4/20 0.39
▸ HPGD P15428 4/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ HSD17B10 Q99714 3/20 0.39
▸ MAPT P10636 4/20 0.38
▸ KMT2A Q03164 3/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ L3MBTL1 Q9Y468 2/20 0.38
▸ HTT P42858 1/20 0.38
▸ NPC1 O15118 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ PABPC1 P11940 1/20 0.37
▸ RXRA P19793 1/20 0.36
▸ RXRB P28702 1/20 0.36
▸ ATM Q13315 1/20 0.36
▸ TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18566133 0.82 GPR3 (0.47) GPR3KIF11KDM4EHPGDALDH1A1
SCHEMBL18566171 0.80 GPR3 (0.44) GPR3KIF11KDM4EHPGDALDH1A1
SCHEMBL18566167 0.78 ALKBH5 (0.41) GPR3KIF11KDM4EHPGDALDH1A1
SCHEMBL18566177 0.77 KDM4E (0.34) GPR3KIF11KDM4EHPGDALDH1A1
SCHEMBL18566122 0.77 GPR3 (0.47) GPR3KIF11KDM4EHPGDALDH1A1
SCHEMBL18566162 0.73 ALKBH5 (0.39) GPR3KIF11KDM4EHPGDALDH1A1
SCHEMBL18416294 0.73 GPR3 (0.57) GPR3KIF11KDM4EHPGDALDH1A1
SCHEMBL18565394 0.72 RXRA (0.50) GPR3KIF11KDM4EHPGDALDH1A1
SCHEMBL20030847 0.72 GPR3 (0.52) GPR3KIF11KDM4EHPGDALDH1A1
SCHEMBL18565391 0.71 KDM4E (0.43) GPR3KIF11KDM4EHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-03-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE EED, BMI1, CD99 GPR3 3915/4885KIF11 3438/4885KDM4E 225/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback